mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.052 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |